Prof Benjamin Solomon
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
767 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
Adjuvant alectinib versus chemotherapy in resected ALK-positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial
DOI: 10.1016/S1470-2045(26)00283-42026
Journal article
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN study
DOI: 10.1016/j.annonc.2026.05.6922026
Journal article
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.
DOI: 10.1158/1078-0432.CCR-26-03332025
Research grants (ARC, NHMRC, MRFF)
Advancing Precision Medicine for Lung Cancer
2020
Journal article
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
DOI: 10.1038/s41388-020-1357-62020
Research Grant
PRedicting the Population Health Economic IMpact of Current and New CAncer Treatments (PRIMCAT)
2020
Research grants (ARC, NHMRC, MRFF)
Delivering Personalised Medicine for Lung Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)
DOI: 10.1016/j.lungcan.2026.1095002026
Journal article
Adjuvant alectinib versus platinum-based chemotherapy in patients from Asia with completely resected ALK-positive non-small cell lung cancer (NSCLC): an exploratory subgroup analysis of ALINA including pharmacokinetics and safety in Japanese patients
DOI: 10.1016/j.ijlcan.2026.1000622026
Journal article
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need
DOI: 10.1016/j.lungcan.2026.1094712026
Journal article
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis
DOI: 10.1093/oncolo/oyag1372026
Journal article
First-line (1L) divarasib plus pembrolizumab (pembro) in advanced or metastatic KRAS G12C non–small cell lung cancer (NSCLC): Results from the Krascendo-170 study.
DOI: 10.1200/jco.2026.44.16_suppl.85102026
Journal article
Implementing targeted thromboprophylaxis as a supportive care model: Mapping implementation preferences across the cancer care pathway.
DOI: 10.1200/jco.2026.44.16_suppl.e135522026
Journal article
Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial
DOI: 10.1016/j.lungcan.2026.109385
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
A vaLue-based Person-Centric Enhanced Health Technology Assessment in CAncer Medicine (ALPACA)